AMERICAN CENTURY COMPANIES INC
Position in DNLI — Denali Therapeutics Inc.
CIK 748054
KANSAS CITY, MO
Position in DNLI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,965,286
+$11,707,154 QoQ
Shares Held
935,692
+146.9% QoQ
Ownership
0.590%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 78.56271080654746.ToString("F0")%
Shared 21.437289193452546.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERICAN CENTURY COMPANIES INC holds $3,844,311,104 across 169 Biotechnology names. DNLI ranks #39 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,802,363 | $596,347,845 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
562,097 | $434,298,626 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
813,285 | $363,164,283 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,397,119 | $319,563,028 | |
| 5 | INSM |
INSMED Inc
|
925,799 | $151,386,652 | |
| 6 | ARGX |
Argenx SE
|
173,700 | $126,844,425 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,663,803 | $124,934,967 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
4,138,416 | $102,467,180 |
All Filings in DNLI
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,965,286 | 935,692 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,258,132 | 379,051 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,188,591 | 357,341 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,451,520 | 318,193 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,750,364 | 349,420 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,793,181 | 480,529 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $13,148,524 | 451,374 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $12,134,632 | 522,594 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $9,429,678 | 459,536 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $10,161,181 | 473,494 | Shares | Defined | 2024-02-13 | |
| 2023-06-30 | $13,985,054 | 473,909 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,915,960 | 473,783 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $13,134,329 | 472,288 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $14,497,158 | 472,374 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,810,939 | 469,281 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $17,258,272 | 536,471 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $23,918,177 | 536,282 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $17,606,394 | 348,987 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $22,970,918 | 292,847 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $16,629,918 | 291,242 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $27,212,618 | 324,888 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $14,922,335 | 416,476 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $10,067,246 | 416,346 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $7,286,278 | 416,121 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||